Latest News

December 12, 2017
Commonwealth Fund researchers said Medicare Advantage plans will need enhanced incentives to make sure that high-quality care is provided at lower cost, as the number of beneficiaries in these plans is expected to climb by 2027.
December 12, 2017
Would you rather have $60 today or $75 next month? Using similar questions, researchers at the University of California San Diego (UCSD) School of Medicine and 23andMe Inc. found a genetic signature for delay discounting that overlaps with attention-deficit/hyperactivity disorder (ADHD), smoking, and weight.
December 12, 2017
Welltok, the consumer health enterprise company, compiled data to help employers, health plans, and other population health managers identify consumers with a higher risk of contracting the flu.
December 12, 2017
FDA is considering a faster approval process for medical devices; the American Clinical Laboratory Association is suing the federal government over a new reimbursement system; there are 2 Obamacare special enrollment periods that a greater-than-usual number of people could be eligible for.
December 11, 2017
A report from the Urban Institute traces CMS' evolving approach to compensating primary care physicians to treat those with multiple chronic conditions.
December 11, 2017
Findings from 3 analyses published in CANCER highlight racial disparities in the survival of patients with ovarian, colon, and breast cancer from 2001-2003 and 2004-2009.
December 11, 2017
The cost of insulin has been a major policy issue in recent years. FDA Commissioner Scott Gottlieb, MD, said the approval of a new choice in insulin was a sign of his commitment to giving patients lower-cost options.
December 11, 2017
A Kaiser Family Foundation web briefing navigated the HIV/AIDS funding landscape, taking a look at trends over time, the latest data, and what we might expect in the future.
December 11, 2017
Health officials are warning of an unusually harsh flu season; Ascension and Providence St. Joseph Health are in talks about a possible merger; and heavy traffic is expected as the final week of ACA sign-ups begins.
December 11, 2017
The Institute for Clinical and Economic Review (ICER) is seeking public comment on its review of 3 calcitonin gene-related peptide (CGRP) inhibitors for prevention of migraine, as well as an update to its 2016 report on treatments for plaque psoriasis.
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome to the new and improved AJMC.com, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!